Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial - Ravnborg, M; Sørensen, P S; Andersson, M (Lancet Neurol, 2010)
, et al.